Parallax Volatility Advisers
SHACW

Parallax Volatility Advisers’s SCP & CO Healthcare Acquisition Company Warrant SHACW Stock Holding History

Parallax Volatility Advisers’s Portfolio SHACW Stock Details SHACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-228,794
Closed -$11K – 3469
2022
Q3 		$11K Buy
228,794
+157,253
+220% +$7.83K ﹤0.01% 2815
2022
Q2 		$6K Hold
71,541
– – ﹤0.01% 2719
2022
Q1 		$15K Buy
71,541
+45,205
+172% +$17.4K ﹤0.01% 2635
2021
Q4 		$14K Buy
+26,336
New +$15.5K ﹤0.01% 1913

Parallax Volatility Advisers's SHACW Position: Q4 2022 in Review

Parallax Volatility Advisers sold out of SCP & CO Healthcare Acquisition Company Warrant (SHACW) in Q4 2022, closing a stake of 228,794 shares — an estimated $11K sold.

Parallax Volatility Advisers first reported a position in SHACW in Q4 2021 and held it in 4 quarters. The position peaked at $15K in Q1 2022. 0 funds tracked by Wall St. Rank hold SHACW as of Q4 2022.

  • Parallax Volatility Advisers reported no remaining SCP & CO Healthcare Acquisition Company Warrant position as of Q4 2022 after selling out during the quarter.
  • Parallax Volatility Advisers sold 228,794 SCP & CO Healthcare Acquisition Company Warrant shares in Q4 2022, an estimated $11K.
  • Parallax Volatility Advisers first reported a position in SCP & CO Healthcare Acquisition Company Warrant in Q4 2021 and held it in 4 quarters.
  • Parallax Volatility Advisers's SCP & CO Healthcare Acquisition Company Warrant position peaked at $15K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Warrant as of Q4 2022.

Based on Parallax Volatility Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.